Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765763 · ClinicalTrials.gov registry record · Phase 4
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
A Phase 4 study of Skin Aging and Photoaging of Skin, sponsored by Advanced Dermatology.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT02765763: Completed Phase 4 study of Skin Aging and Photoaging of Skin, sponsored by Advanced Dermatology.
NCT02765763 is a Phase 4 study of Skin Aging and Photoaging of Skin that has completed, run by Advanced Dermatology. The registered enrollment target is 45 participants, below the 70-participant average among 9 other Skin Aging trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765763, a Phase 4 study of Skin Aging and Photoaging of Skin, has completed, sponsored by Advanced Dermatology.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the skin of human subjects.
Conditions Studied
Interventions
- DRUG 2-Minute Reveal Masque
- DRUG 24/7 Barrier Repair Cream
- DRUG 8-in-1 BioSerum
- DRUG Null Formula 2-Minute Reveal Masque
- DRUG Null Formula 24/7 Barrier Repair Cream
Study Locations (1)
Illinois
- Advanced Dermatology, LLC - Lincolnshire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
What the finished NCT02765763 record still lists
NCT02765763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 70-participant average among 9 other Skin Aging trials with a reported enrollment target (36% lower).
The record links to 2 conditions, with Skin Aging appearing as the primary indexed condition, and to 5 interventions - of which 2-Minute Reveal Masque is the first listed.
NCT02765763 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02765763 about?
NCT02765763 is a clinical study titled "Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules". This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the ski...
What is the current status of trial NCT02765763?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2017-06.
What conditions does trial NCT02765763 study?
This clinical trial studies the following conditions: Skin Aging, Photoaging of Skin.
What interventions are being tested in trial NCT02765763?
The interventions under investigation include: 2-Minute Reveal Masque (DRUG), 24/7 Barrier Repair Cream (DRUG), 8-in-1 BioSerum (DRUG), Null Formula 2-Minute Reveal Masque (DRUG), Null Formula 24/7 Barrier Repair Cream (DRUG).
Who is sponsoring clinical trial NCT02765763?
This trial is sponsored by Advanced Dermatology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02765763 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02765763's enrollment target sits among peer trials
45 5th of 9 higher than 5 of 9 other Skin Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
ACTIVE NOT RECRUITING · Early Phase 1
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia